LPTX — LEAP THERAPEUTICS INC

Ownership history in GILEAD SCIENCES, INC.  ·  4 quarters on record

This page tracks every 13F SEC filing in which GILEAD SCIENCES, INC. reported a position in LEAP THERAPEUTICS INC (LPTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.99% (2024 Q4)
Avg. % of fund
0.35%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 5,319,148 — 0% 0.13% $2.4M —
2025 Q2 UNCHANGED 5,319,148 — 0% 0.12% $1.58B —
2025 Q1 UNCHANGED 5,319,148 — 0% 0.14% $1.62B —
2024 Q4 INITIATED 5,319,148 — — 0.99% $15.29B —
% of Fund (quarterly)

Other funds also holding LPTX

As of 2025 Q4 — sorted by position size

Simplify Asset Management Inc. 3Y 0.04% Key Client Fiduciary Advisors, LLC 3Y 0.03% Keystone Financial Group 3Y 7Y 0.0% OPTIMA CAPITAL LLC 0.0% Tower Research Capital LLC (TRC) 3Y 7Y 0.0% GROUP ONE TRADING LLC 3Y 7Y 0.0% Sequoia Financial Advisors, LLC 3Y 7Y 0.0% IHT Wealth Management, LLC 3Y 7Y 0.0% TWO SIGMA INVESTMENTS, LP 3Y 7Y 0.0% Tidal Investments LLC 3Y 7Y 0.0%
← Back to GILEAD SCIENCES, INC. Holdings